PATENT CLAIM ANALYSIS

Application Number: 16196038
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["544", "331000"]

Abstract:
Disclosed are compounds of formula (I), pharmaceutical compositions comprising such compounds and methods/uses of using the same, for example, for treating a JAK-related disorder, such as cancer, cancer cachexia or an immune disorder: wherein R 1  is methyl or ethyl; R 2  is selected from methyl, ethyl, methoxy and ethoxy; R 3  is selected from hydrogen, chlorine, fluorine, bromine and methyl; R 4  is selected from methyl, ethyl and —CH 2 OCH 3 ; R 5  and R 6  are each individually methyl or hydrogen; and R 7  is selected from methyl, ethyl, —(CH 2 ) 2 OH and —(CH 2 ) 2 OCH 3 , or a pharmaceutically acceptable salt thereof.

Claim (Index 21):
The solvate form of  claim 10  which has an XRPD pattern comprising at least one specific peak expressed as 2\u03b8 (\u00b10.2\u00b0) selected from 16.3\u00b0, 23.9\u00b0, 24.4\u00b0, 25.1\u00b0, 28.1\u00b0, 29.3\u00b0, 31.8\u00b0, 32.7\u00b0 and 37.5\u00b0.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 2.14062
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15272554', '15601324', '13592389', '14326051', '15269485']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8000311289837984
- 35 USC 102 Novelty (BERT): 0.6128701039257894
- Combined Prediction Score: 0.7813150264779976
- Mean Citation Score: 504.14294200000006
- Max Citation Score: 749.4870599999997
- Similarity Product: 466.99755638947954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test